Q-linea AB (publ) Stock: price and insider trades · Sweden

Q-linea AB (publ), classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finansinspektionen. In the past year (18 October 2025 to 18 October 2026), 5 filings came from 2 insiders.

Both sides are active: 4 purchases worth €32k and 1 sale worth €1,999, from 2 insiders and 1 insider respectively. Taken together, the purchases exceed the sales by €30k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. On the buying side, the filings list 1 senior executive and 1 chief executive among the declarants. One trade stands out by size: a purchase of €18k from Stuart Gander, disclosed on 4 June 2026.

Across the 886 companies tracked on its exchange, the median is 8 filings; at 5 filings, this issuer sits below that mark. Our records for Q-linea AB (publ) go back to 2026, with 4 purchases and 1 sale on the open market in total.

In all, 1 purchase was made within 30 days of a purchase by another insider of the company. Purchases made close together by different insiders form what is called a cluster. The clock since the last published purchase (8 June 2026) now reads 132 days. Filings reach the Finansinspektionen feed a median of 3 days after the trade. The legal deadline for notifying a trade is three business days (MAR article 19).

For comparison within the same sector, see the insider buying recorded at Cooper Companies, Inc. and Anixa Biosciences Inc. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.